The store will not work correctly when cookies are disabled.
3-(2,4-diaminopyrimidin-5-yl)-1-(4-methoxyphenyl)prop-2-en-1-one
ID: ALA1094564
PubChem CID: 46888229
Max Phase: Preclinical
Molecular Formula: C14H14N4O2
Molecular Weight: 270.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)/C=C/c2cnc(N)nc2N)cc1
Standard InChI: InChI=1S/C14H14N4O2/c1-20-11-5-2-9(3-6-11)12(19)7-4-10-8-17-14(16)18-13(10)15/h2-8H,1H3,(H4,15,16,17,18)/b7-4+
Standard InChI Key: HPQVWFWQLGFBDK-QPJJXVBHSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
13.1527 -6.2750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1516 -7.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8664 -7.5152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5828 -7.1019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5800 -6.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8646 -5.8622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4368 -7.5143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8621 -5.0372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2929 -5.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0089 -6.2659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7218 -5.8508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4378 -6.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7187 -5.0258 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4378 -7.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1530 -7.4941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8669 -7.0789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8611 -6.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1454 -5.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5832 -7.4876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2956 -7.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 10 2 0
2 3 1 0
10 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
11 13 2 0
1 2 2 0
12 14 2 0
2 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
6 8 1 0
16 17 1 0
17 18 2 0
18 12 1 0
5 9 1 0
4 5 1 0
19 20 1 0
16 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.29 | Molecular Weight (Monoisotopic): 270.1117 | AlogP: 1.55 | #Rotatable Bonds: 4 |
Polar Surface Area: 104.12 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.27 | CX LogP: 1.42 | CX LogD: 1.20 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.64 | Np Likeness Score: -0.32 |
References
1. Bag S, Tawari NR, Degani MS, Queener SF.. (2010) Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens., 18 (9): [PMID:20363634] [10.1016/j.bmc.2010.03.031] |